Johnson & Johnson COVID-19 vaccine booster, after single dose primary regimen, provided rapid and robust increase in spike-binding antibodies
New studies build on data demonstrating strong durability through eight months after immunization
https://finance.yahoo.com/news/johnson-johnson-announces-data-support-104500343.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.